Stocks
Walgreens Boots Alliance Financial Statements (WBA) |
||||||||||
| Walgreens Boots Alliancesmart-lab.ru | % | 2021 | 2021 | 2022 | 2023 | LTM ? | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 14.10.2021 | 24.11.2021 | 06.01.2022 | 13.10.2022 | 12.10.2023 | 28.03.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 132 509 | 132 509 | 132 703 | 139 081 | 144 596 | ||||
| Operating Income, bln rub | 3 481 | 2 342 | 4 385 | -6 882 | -829.0 | |||||
| EBITDA, bln rub | ? | 5 454 | 6 087 | 6 375 | -2 582 | 1 613 | ||||
| Net profit, bln rub | ? | 1 328 | 2 542 | 4 337 | -3 080 | -6 206 | ||||
| OCF, bln rub | ? | 5 555 | 5 555 | 3 899 | 2 258 | 101.0 | ||||
| CAPEX, bln rub | ? | 1 379 | 1 379 | 1 734 | 2 117 | 1 867 | ||||
| FCF, bln rub | ? | 4 176 | 4 176 | 2 165 | 141.0 | -1 766 | ||||
| Dividend payout, bln rub | 1 617 | 1 617 | 1 659 | 1 659 | 1 658 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 121.8% | 63.6% | 38.3% | 0.00% | -26.7% | |||||
| OPEX, bln rub | 24 586 | 24 586 | 27 295 | 34 205 | 27 521 | |||||
| Cost of production, bln rub | 104 442 | 104 442 | 104 437 | 112 009 | 118 335 | |||||
| R&D, bln rub | 284.0 | 0.000 | 307.0 | 371.0 | 371.0 | |||||
| Interest expenses, bln rub | 905.0 | 905.0 | 400.0 | 580.0 | 565.0 | |||||
| Assets, bln rub | 81 285 | 81 285 | 96 507 | 90 124 | 96 628 | 84 207 | ||||
| Net Assets, bln rub | ? | 23 822 | 23 419 | 30 579 | 29 366 | 20 021 | 13 484 | |||
| Debt, bln rub | 33 392 | 33 393 | 13 846 | 35 477 | 33 534 | 34 627 | ||||
| Cash, bln rub | 1 193 | 1 193 | 4 135 | 2 472 | 739.0 | 668.0 | ||||
| Net debt, bln rub | 32 199 | 32 200 | 9 711 | 33 005 | 32 795 | 33 959 | ||||
| Ordinary share price, rub | 50.8 | 50.8 | 49.2 | 35.1 | 25.3 | 21.5 | ||||
| Number of ordinary shares, mln | 864.8 | 864.8 | 864.4 | 863.2 | 862.5 | |||||
| Market cap, bln rub | 43 889 | 43 889 | 0 | 30 306 | 21 848 | 18 570 | ||||
| EV, bln rub | ? | 76 088 | 76 089 | 9 711 | 63 311 | 54 643 | 52 529 | |||
| Book value, bln rub | 1 465 | 1 061 | -3 711 | -3 644 | -21 801 | -15 313 | ||||
| EPS, rub | ? | 1.54 | 2.94 | 5.02 | -3.57 | -7.20 | ||||
| FCF/share, rub | 4.83 | 4.83 | 2.50 | 0.16 | -2.05 | |||||
| BV/share, rub | 1.69 | 1.23 | -4.22 | -25.3 | -17.8 | |||||
| EBITDA margin, % | ? | 4.12% | 4.59% | 4.80% | -1.86% | 1.12% | ||||
| Net margin, % | ? | 1.00% | 1.92% | 3.27% | -2.21% | -4.29% | ||||
| FCF yield, % | ? | 9.51% | 9.51% | 0.00% | 7.14% | 0.65% | -9.51% | |||
| ROE, % | ? | 5.57% | 10.9% | 0.00% | 14.8% | -15.4% | -46.0% | |||
| ROA, % | ? | 1.63% | 3.13% | 0.00% | 4.81% | -3.19% | -7.37% | |||
| P/E | ? | 33.0 | 17.3 | 6.99 | -7.09 | -2.99 | ||||
| P/FCF | 10.5 | 10.5 | 14.0 | 154.9 | -10.5 | |||||
| P/S | ? | 0.33 | 0.33 | 0.23 | 0.16 | 0.13 | ||||
| P/BV | ? | 30.0 | 41.4 | 0.00 | -8.32 | -1.00 | -1.21 | |||
| EV/EBITDA | ? | 14.0 | 12.5 | 9.93 | -21.2 | 32.6 | ||||
| Debt/EBITDA | 5.90 | 5.29 | 5.18 | -12.7 | 21.1 | |||||
| R&D/CAPEX, % | 20.6% | 0.00% | 17.7% | 17.5% | 19.9% | |||||
| CAPEX/Revenue, % | 1.04% | 1.04% | 1.31% | 1.52% | 1.29% | |||||
| Walgreens Boots Alliance shareholders | ||||||||||
